Edition:
United Kingdom

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

5.35USD
19 Jul 2019
Change (% chg)

$-0.10 (-1.83%)
Prev Close
$5.45
Open
$5.42
Day's High
$5.42
Day's Low
$5.35
Volume
5,938
Avg. Vol
12,268
52-wk High
$7.50
52-wk Low
$3.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.707
Mar '19 0.00 -0.784
FY 2018 Dec '18 0.00 -0.957
Sep '18 0.00 -0.925
Jun '18 0.00 -1.332
Mar '18 0.00 -1.333
FY 2017 Dec '17 0.00 0.605
Sep '17 0.00 -0.403
Jun '17 0.00 -2.184
Mar '17 0.00 -2.201
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.41 32.67
P/E High - Last 5 Yrs. -- 147.75 47.29
P/E Low - Last 5 Yrs. -- 48.01 23.88
Beta 1.75 1.09 0.89
Price to Sales (TTM) 2.10 49.46 7.92
Price to Book (MRQ) 1.76 10.14 5.39
Price to Tangible Book (MRQ) 1.76 13.75 6.71
Price to Cash Flow (TTM) -- 55.97 24.37
% Owned Institutions 48.56 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.00 40.25

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.69 12.24
Sales (TTM) vs TTM 1 Yr. Ago 135.90 49.06 7.74
Sales - 5 Yr. Growth Rate 33.35 22.81 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.43 75.26 43.01
EPS (TTM) vs TTM 1 Yr. Ago 39.54 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -3.42 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 2.45 3.59 3.03
LT Debt to Equity (MRQ) 45.92 18.58 10.21
Total Debt to Equity (MRQ) 45.92 31.20 14.56
Interest Coverage (TTM) -5.19 -43.39 29.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 95.15 56.07 52.21
Gross Margin - 5 Yr. Avg. -- 60.31 50.40
EBITD Margin (TTM) -112.88 -- --
EBITD - 5 Yr. Avg -113.42 -110.44 13.16
Operating Margin (TTM) -125.35 -184.27 6.88
Operating Margin - 5 Yr. Avg. -119.92 -126.89 8.97
Pre-Tax Margin (TTM) -171.30 -175.02 6.08
Pre-Tax Margin - 5 Yr. Avg. -140.26 -132.65 9.26
Net Profit Margin (TTM) -137.45 -181.72 2.72
Net Profit Margin - 5 Yr. Avg. -140.26 -137.02 5.63
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 303,779 7,672,423 887,716,663
Net Income/Employee (TTM) -417,531 533,977 101,894,138
Receivable Turnover (TTM) 9.22 6.28 5.94
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.49 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.55 6.42 11.18
Return on Assets - 5 Yr. Avg. -74.23 5.51 12.34
Return on Investment (TTM) -113.12 8.94 14.49
Return on Investment - 5 Yr. Avg. -135.07 6.84 16.03
Return on Equity (TTM) -- 10.07 15.79
Return on Equity - 5 Yr. Avg. -- 8.42 17.02
  1 Year 3 Year 5 Year
Sales % 61.64 44.53 33.35
EPS (TTM) % 8.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Merrimack Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.43 -3.04 44 99
13 Week -4.08 -8.75 43 95
26 Week -32.70 -37.82 20 97
52 Week -65.34 -70.62 11 70
YTD -49.20 -55.38 12 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.40%
# of Holders: 65
Total Shares Held: 6,861,997
3 Mo. Net Change: 245,441
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 0
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.